FDO Partners’s Amgen AMGN Stock Holding History

FDO Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,074	Closed	-$874K	–	216
2017 Q2	$874K	Buy	+5,074	New	+$825K	0.19%	180

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDO Partners's AMGN Position: Q3 2017 in Review

FDO Partners sold out of Amgen (AMGN) in Q3 2017, closing a stake of 5,074 shares — an estimated $874K sold.

FDO Partners first reported a position in AMGN in Q2 2017 and held it in 1 quarter. The position peaked at $874K in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

FDO Partners reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
FDO Partners sold 5,074 Amgen shares in Q3 2017, an estimated $874K.
FDO Partners first reported a position in Amgen in Q2 2017 and held it in 1 quarter.
FDO Partners's Amgen position peaked at $874K in Q2 2017.
1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on FDO Partners's 13F filing for Q3 2017, filed 13 Nov 2017.